{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T01:53:49Z","timestamp":1793325229346,"version":"4.5.0"},"reference-count":144,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,1,18]],"date-time":"2021-01-18T00:00:00Z","timestamp":1610928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,1,18]],"date-time":"2021-01-18T00:00:00Z","timestamp":1610928000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100006245","name":"Ministry of Science and Technology, Israel","doi-asserted-by":"publisher","award":["Scholarship number 3-16752"],"award-info":[{"award-number":["Scholarship number 3-16752"]}],"id":[{"id":"10.13039\/501100006245","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharmacol. Rep"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1007\/s43440-020-00206-y","type":"journal-article","created":{"date-parts":[[2021,1,18]],"date-time":"2021-01-18T11:14:29Z","timestamp":1610968469000},"page":"443-453","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Pruritus in psoriasis and atopic dermatitis: current treatments and new perspectives"],"prefix":"10.1007","volume":"73","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5213-2599","authenticated-orcid":false,"given":"Shirin","family":"Kahremany","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0157-0526","authenticated-orcid":false,"given":"Lukas","family":"Hofmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Harari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arie","family":"Gruzman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9608-1081","authenticated-orcid":false,"given":"Guy","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,18]]},"reference":[{"key":"206_CR1","doi-asserted-by":"publisher","first-page":"3052","DOI":"10.1038\/s41467-020-16859-5","volume":"11","author":"XJ Chen","year":"2020","unstructured":"Chen XJ, Sun YG. Central circuit mechanisms of itch. Nat Commun. 2020;11:3052.","journal-title":"Nat Commun"},{"key":"206_CR2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1093\/qjmed\/hcg002","volume":"96","author":"R Twycross","year":"2003","unstructured":"Twycross R, Greaves MW, Handwerker H, Jones EA, Libretto SE, Szepietowski JC, et al. Itch: scratching more than the surface. QJM. 2003;96:7\u201326.","journal-title":"QJM"},{"key":"206_CR3","doi-asserted-by":"publisher","first-page":"291","DOI":"10.2340\/00015555-0305","volume":"87","author":"S St\u00e4nder","year":"2007","unstructured":"St\u00e4nder S, Weisshaar E, Mettang T, Szepietowski JC, Carstens E, Ikoma A, et al. Clinical classification of itch: a position paper of the International Forum for the Study of Itch. Acta Derm Venereol. 2007;87:291\u20134.","journal-title":"Acta Derm Venereol"},{"key":"206_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000446009","volume-title":"Classification of itch. Itch-management in clinical practice","author":"S St\u00e4nder","year":"2016","unstructured":"St\u00e4nder S. Classification of itch. Itch-management in clinical practice. Berlin: Karger Publishers; 2016. p. 1\u20134."},{"key":"206_CR5","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.neuron.2018.03.023","volume":"98","author":"X Dong","year":"2018","unstructured":"Dong X, Dong X. Peripheral and central mechanisms of itch. Neuron. 2018;98:482\u201394.","journal-title":"Neuron"},{"key":"206_CR6","doi-asserted-by":"publisher","first-page":"167","DOI":"10.3389\/fmed.2019.00167","volume":"6","author":"M Schmelz","year":"2019","unstructured":"Schmelz M. Itch processing in the skin. Front Med. 2019;6:167.","journal-title":"Front Med"},{"key":"206_CR7","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1111\/dth.12025","volume":"26","author":"L Garibyan","year":"2013","unstructured":"Garibyan L, Rheingold CG, Lerner EA. Understanding the pathophysiology of itch. Dermatol Ther. 2013;26:84\u201391.","journal-title":"Dermatol Ther"},{"key":"206_CR8","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1038\/nrneurol.2014.99","volume":"10","author":"L Misery","year":"2014","unstructured":"Misery L, Brenaut E, Le Garrec R, Abasq C, Genestet S, Marcorelles P, et al. Neuropathic pruritus. Nat Rev Neurol. 2014;10:408\u201316.","journal-title":"Nat Rev Neurol"},{"key":"206_CR9","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.sder.2011.04.006","volume":"30","author":"AL Oaklander","year":"2011","unstructured":"Oaklander AL. Neuropathic itch. Semin Cutan Med Surg. 2011;30:87\u201392.","journal-title":"Semin Cutan Med Surg"},{"key":"206_CR10","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1111\/dth.12028","volume":"26","author":"A Stumpf","year":"2013","unstructured":"Stumpf A, St\u00e4nder S. Neuropathic itch: diagnosis and management. Dermatol Ther. 2013;26:104\u20139.","journal-title":"Dermatol Ther"},{"key":"206_CR11","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1016\/S0140-6736(03)12570-6","volume":"361","author":"G Yosipovitch","year":"2003","unstructured":"Yosipovitch G, Greaves MW, Schmelz M. Itch. Lancet. 2003;361:690\u20134.","journal-title":"Lancet"},{"key":"206_CR12","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1111\/j.1529-8019.2008.00167.x","volume":"21","author":"G Yosipovitch","year":"2008","unstructured":"Yosipovitch G, Samuel LS. Neuropathic and psychogenic itch. Dermatol Ther. 2008;21:32\u201341.","journal-title":"Dermatol Ther"},{"key":"206_CR13","first-page":"30","volume":"2","author":"YA Tivoli","year":"2009","unstructured":"Tivoli YA, Rubenstein RM. Pruritus: an updated look at an old problem. J Clin Aesthet Dermatol. 2009;2:30\u20136.","journal-title":"J Clin Aesthet Dermatol"},{"key":"206_CR14","doi-asserted-by":"publisher","first-page":"xiv","DOI":"10.1111\/j.1523-1747.2003.12650.x","volume":"121","author":"G Yosipovitch","year":"2003","unstructured":"Yosipovitch G. Assessment of itch: more to be learned and improvements to be made. J Investig Dermatol. 2003;121:xiv\u2013xv.","journal-title":"J Investig Dermatol"},{"key":"206_CR15","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/j.cpha.2016.06.004","volume":"1","author":"A Weissler","year":"2016","unstructured":"Weissler A. Atopic dermatitis\u2014a new dawn. Physician Assist Clin. 2016;1:661\u201382.","journal-title":"Physician Assist Clin"},{"key":"206_CR16","doi-asserted-by":"publisher","first-page":"39","DOI":"10.2340\/00015555-0554","volume":"89","author":"JA Halvorsen","year":"2009","unstructured":"Halvorsen JA, Dalgard F, Thoresen M, Thoresen M, Bjertness E, Lien L. Itch and mental distress: a cross-sectional study among late adolescents. Acta Derm Venereol. 2009;89:39\u201344.","journal-title":"Acta Derm Venereol"},{"key":"206_CR17","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1046\/j.1087-0024.2003.09111.x","volume":"9","author":"F Dalgard","year":"2004","unstructured":"Dalgard F, Svensson A, Holm JO, Sundby J. Self-reported skin morbidity among adults: associations with quality of life and general health in a Norwegian survey. J Investig Dermatol Symp Proc. 2004;9:120\u20135.","journal-title":"J Investig Dermatol Symp Proc"},{"key":"206_CR18","doi-asserted-by":"publisher","first-page":"508","DOI":"10.2340\/00015555-1221","volume":"92","author":"R Zachariae","year":"2012","unstructured":"Zachariae R, Lei U, Haedersdal M, Zachariae C. Itch severity and quality of life in patients with pruritus: preliminary validity of a Danish adaptation of the itch severity scale. Acta Derm Venereol. 2012;92:508\u201314.","journal-title":"Acta Derm Venereol"},{"key":"206_CR19","doi-asserted-by":"publisher","first-page":"133","DOI":"10.3390\/children6120133","volume":"6","author":"CH Na","year":"2019","unstructured":"Na CH, Chung J, Simpson EL. Quality of life and disease impact of atopic dermatitis and psoriasis on children and their families. Children. 2019;6:133.","journal-title":"Children"},{"key":"206_CR20","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1007\/s11882-008-0049-z","volume":"8","author":"G Yosipovitch","year":"2008","unstructured":"Yosipovitch G, Papoiu AD. What causes itch in atopic dermatitis? Curr Allergy Asthma Rep. 2008;8:306\u201311.","journal-title":"Curr Allergy Asthma Rep"},{"key":"206_CR21","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1016\/j.jaci.2018.09.005","volume":"142","author":"G Yosipovitch","year":"2018","unstructured":"Yosipovitch G, Rosen JD, Hashimoto T. Itch: from mechanism to (novel) therapeutic approaches. J Allergy Clin Immunol. 2018;142:1375\u201390.","journal-title":"J Allergy Clin Immunol"},{"key":"206_CR22","doi-asserted-by":"publisher","first-page":"884","DOI":"10.3390\/jcm4050884","volume":"4","author":"EC Siegfried","year":"2015","unstructured":"Siegfried EC, Hebert AA. Diagnosis of atopic dermatitis: mimics, overlaps, and complications. J Clin Med. 2015;4:884\u2013917.","journal-title":"J Clin Med"},{"key":"206_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/mus.23510","volume":"47","author":"MI Myers","year":"2013","unstructured":"Myers MI, Peltier AC, Li J. Evaluating dermal myelinated nerve fibers in skin biopsy. Muscle Nerve. 2013;47:1\u201311.","journal-title":"Muscle Nerve"},{"key":"206_CR24","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1159\/000446012","volume-title":"Peripheral mechanisms of itch. Itch-management in clinical practice","author":"E Azimi","year":"2016","unstructured":"Azimi E, Xia J, Lerner EA. Peripheral mechanisms of itch. Itch-management in clinical practice. Berlin: Karger Publishers; 2016. p. 18\u201323."},{"key":"206_CR25","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.neubiorev.2008.12.004","volume":"34","author":"M Schmelz","year":"2010","unstructured":"Schmelz M. Itch and pain. Neurosci Biobehav Rev. 2010;34:171\u20136.","journal-title":"Neurosci Biobehav Rev"},{"key":"206_CR26","doi-asserted-by":"publisher","first-page":"8003","DOI":"10.1523\/JNEUROSCI.17-20-08003.1997","volume":"17","author":"M Schmelz","year":"1997","unstructured":"Schmelz M, Schmidt R, Bickel A, Handwerker HO, Torebj\u00f6rk HE. Specific C-receptors for itch in human skin. J Neurosci. 1997;17:8003.","journal-title":"J Neurosci"},{"key":"206_CR27","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/j.immuni.2020.04.008","volume":"52","author":"F Wang","year":"2020","unstructured":"Wang F, Kim BS. Itch: a paradigm of neuroimmune crosstalk. Immunity. 2020;52:753\u201366.","journal-title":"Immunity"},{"key":"206_CR28","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1111\/1346-8138.12317","volume":"41","author":"M Tominaga","year":"2014","unstructured":"Tominaga M, Takamori K. Itch and nerve fibers with special reference to atopic dermatitis: therapeutic implications. J Dermatol. 2014;41:205\u201312.","journal-title":"J Dermatol"},{"key":"206_CR29","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s00281-015-0530-4","volume":"38","author":"S Sun","year":"2016","unstructured":"Sun S, Dong X. Trp channels and itch. Semin Immunopathol. 2016;38:293\u2013307.","journal-title":"Semin Immunopathol"},{"key":"206_CR30","doi-asserted-by":"publisher","first-page":"14841","DOI":"10.1523\/JNEUROSCI.3005-11.2011","volume":"31","author":"M Ringkamp","year":"2011","unstructured":"Ringkamp M, Schepers RJ, Shimada SG, Johanek LM, Hartke TV, Borzan J, et al. A role for nociceptive, myelinated nerve fibers in itch sensation. J Neurosci. 2011;31:14841\u20139.","journal-title":"J Neurosci"},{"key":"206_CR31","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/j.1365-2222.2011.03791.x","volume":"42","author":"C Potenzieri","year":"2012","unstructured":"Potenzieri C, Undem BJ. Basic mechanisms of itch. Clin Exp Allergy. 2012;42:8\u201319.","journal-title":"Clin Exp Allergy"},{"key":"206_CR32","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/nn.3881","volume":"18","author":"D Usoskin","year":"2015","unstructured":"Usoskin D, Furlan A, Islam S, Abdo H, L\u00f6nnerberg P, Lou D, et al. Unbiased classification of sensory neuron types by large-scale single-cell RNA sequencing. Nat Neurosci. 2015;18:145\u201353.","journal-title":"Nat Neurosci"},{"key":"206_CR33","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1093\/brain\/awt158","volume":"137","author":"A Dhand","year":"2014","unstructured":"Dhand A, Aminoff MJ. The neurology of itch. Brain. 2014;137:313\u201322.","journal-title":"Brain"},{"key":"206_CR34","doi-asserted-by":"publisher","first-page":"474","DOI":"10.5483\/BMBRep.2016.49.9.108","volume":"49","author":"JS Lee","year":"2016","unstructured":"Lee JS, Han JS, Lee K, Bang J, Lee H. The peripheral and central mechanisms underlying itch. BMB Rep. 2016;49:474.","journal-title":"BMB Rep"},{"key":"206_CR35","doi-asserted-by":"crossref","unstructured":"Ikoma A, Cevikbas F, Kempkes C, Steinhoff M. Anatomy and neurophysiology of pruritus. Semin Cutan Med Surg. NIH Public Access; 2011;30:64\u201370.","DOI":"10.1016\/j.sder.2011.04.001"},{"key":"206_CR36","doi-asserted-by":"crossref","unstructured":"Kahremany S, Hofmann L, Gruzman A, Cohen G. Advances in understanding the initial steps of pruritoceptive itch: how the itch hits the switch. Int J Mol Sci. 2020;21.","DOI":"10.3390\/ijms21144883"},{"key":"206_CR37","doi-asserted-by":"publisher","first-page":"9","DOI":"10.2147\/CCID.S4465","volume":"2","author":"F Prignano","year":"2009","unstructured":"Prignano F, Ricceri F, Pescitelli L, Lotti T. Itch in psoriasis: epidemiology, clinical aspects and treatment options. Clin Cosmet Investig Dermatol. 2009;2:9\u201313.","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"206_CR38","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s13555-016-0167-9","volume":"7","author":"E Christopher","year":"2017","unstructured":"Christopher E, Griffiths M, van de Kerkhof P, Czarnecka-operacz M. Psoriasis and atopic dermatitis. Dermatol Ther. 2017;7:31.","journal-title":"Dermatol Ther"},{"key":"206_CR39","doi-asserted-by":"publisher","first-page":"108","DOI":"10.3390\/children6100108","volume":"6","author":"R Chovatiya","year":"2019","unstructured":"Chovatiya R, Silverberg JI. Pathophysiology of atopic dermatitis and psoriasis: implications for management in children. Children. 2019;6:108.","journal-title":"Children"},{"key":"206_CR40","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1016\/j.jid.2017.12.029","volume":"138","author":"LA Nattkemper","year":"2018","unstructured":"Nattkemper LA, Tey HL, Valdes-Rodriguez R, Lee H, Mollanazar NK, Albornoz C, et al. The genetics of chronic itch: gene expression in the skin of patients with atopic dermatitis and psoriasis with severe itch. J Investig Dermatol. 2018;138:1311\u20137.","journal-title":"J Investig Dermatol"},{"key":"206_CR41","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1016\/j.jaci.2015.03.003","volume":"135","author":"M Su\u00e1rez-Fari\u00f1as","year":"2015","unstructured":"Su\u00e1rez-Fari\u00f1as M, Ungar B, Correa da Rosa J, Ewald DA, Rozenblit M, Gonzalez J, et al. RNA sequencing atopic dermatitis transcriptome profiling provides insights into novel disease mechanisms with potential therapeutic implications. J Allergy Clin Immunol. 2015;135:1218\u201327.","journal-title":"J Allergy Clin Immunol"},{"key":"206_CR42","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1038\/jid.2011.267","volume":"132","author":"A Jabbari","year":"2012","unstructured":"Jabbari A, Su\u00e1rez-Fari\u00f1as M, Dewell S, Krueger JG. Transcriptional profiling of psoriasis using RNA-seq reveals previously unidentified differentially expressed genes. J Investig Dermatol. 2012;132:246\u20139.","journal-title":"J Investig Dermatol"},{"key":"206_CR43","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1016\/j.jid.2017.02.972","volume":"137","author":"MK Sarkar","year":"2017","unstructured":"Sarkar MK, Kaplan N, Tsoi LC, Xing X, Liang Y, Swindell WR, et al. Endogenous glucocorticoid deficiency in psoriasis promotes inflammation and abnormal differentiation. J Investig Dermatol. 2017;137:1474\u201383.","journal-title":"J Investig Dermatol"},{"key":"206_CR44","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.thromres.2020.08.004","volume":"196","author":"X Han","year":"2020","unstructured":"Han X, Nieman MT. The domino effect triggered by the tethered ligand of the protease activated receptors. Thromb Res. 2020;196:87\u201398.","journal-title":"Thromb Res"},{"key":"206_CR45","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.neuron.2010.10.018","volume":"68","author":"KN Patel","year":"2010","unstructured":"Patel KN, Dong X. An itch to be scratched. Neuron. 2010;68:334\u20139.","journal-title":"Neuron"},{"key":"206_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-019-44866-0","volume":"9","author":"S Takahashi","year":"2019","unstructured":"Takahashi S, Ishida A, Kubo A, Kawasaki H, Ochiai S, Nakayama M, et al. Homeostatic pruning and activity of epidermal nerves are dysregulated in barrier-impaired skin during chronic itch development. Sci Rep. 2019;9:1\u201315.","journal-title":"Sci Rep"},{"key":"206_CR47","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1146\/annurev-biophys-051013-022826","volume":"43","author":"L Han","year":"2014","unstructured":"Han L, Dong X. Itch mechanisms and circuits. Annu Rev Biophys. 2014;43:331\u201355.","journal-title":"Annu Rev Biophys"},{"key":"206_CR48","doi-asserted-by":"crossref","unstructured":"Rendon A, Schakel K. Psoriasis pathogenesis and treatment. Int J Mol Sci. 2019;20.","DOI":"10.3390\/ijms20061475"},{"key":"206_CR49","doi-asserted-by":"publisher","first-page":"392","DOI":"10.5114\/reum.2018.80718","volume":"56","author":"K Dopytalska","year":"2018","unstructured":"Dopytalska K, Sobolewski P, B\u0142aszczak A, Szyma\u0144ska E, Walecka I. Psoriasis in special localizations. Reumatologia. 2018;56:392\u20138.","journal-title":"Reumatologia"},{"key":"206_CR50","first-page":"99","volume":"15","author":"E Kopel","year":"2013","unstructured":"Kopel E, Levi A, Harari M, Ruzicka T, Ingber A. Effect of the Dead Sea climatotherapy for psoriasis on quality of life. Isr Med Assoc J. 2013;15:99\u2013102.","journal-title":"Isr Med Assoc J"},{"key":"206_CR51","doi-asserted-by":"publisher","first-page":"a015354","DOI":"10.1101\/cshperspect.a015354","volume":"4","author":"P Di Meglio","year":"2014","unstructured":"Di Meglio P, Villanova F, Nestle FO. Psoriasis. Cold Spring Harb Perspect Med. 2014;4:a015354.","journal-title":"Cold Spring Harb Perspect Med"},{"key":"206_CR52","doi-asserted-by":"publisher","first-page":"16082","DOI":"10.1038\/nrdp.2016.82","volume":"2","author":"JE Greb","year":"2016","unstructured":"Greb JE, Goldminz AM, Elder JT, Lebwohl MG, Gladman DD, Wu JJ, et al. Psoriasis. Nat Rev Dis Primers. 2016;2:16082.","journal-title":"Nat Rev Dis Primers"},{"key":"206_CR53","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1146\/annurev-immunol-032713-120225","volume":"32","author":"MA Lowes","year":"2014","unstructured":"Lowes MA, Su\u00e1rez-Fari\u00f1as M, Krueger JG. Immunology of psoriasis. Annu Rev Immunol. 2014;32:227\u201355.","journal-title":"Annu Rev Immunol"},{"key":"206_CR54","first-page":"79","volume":"3","author":"G Sarac","year":"2016","unstructured":"Sarac G, Koca TT, Baglan T. A brief summary of clinical types of psoriasis. North Clin Istanb. 2016;3:79\u201382.","journal-title":"North Clin Istanb"},{"key":"206_CR55","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1002\/ejp.768","volume":"20","author":"J Szepietowski","year":"2016","unstructured":"Szepietowski J, Reich A. Pruritus in psoriasis: an update. Eur J Pain. 2016;20:41\u20136.","journal-title":"Eur J Pain"},{"key":"206_CR56","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1046\/j.1365-2133.2000.03829.x","volume":"143","author":"G Yosipovitch","year":"2000","unstructured":"Yosipovitch G, Goon A, Wee J, Chan YH, Goh CL. The prevalence and clinical characteristics of pruritus among patients with extensive psoriasis. Br J Dermatol. 2000;143:969\u201373.","journal-title":"Br J Dermatol"},{"key":"206_CR57","doi-asserted-by":"publisher","first-page":"457","DOI":"10.5114\/ada.2017.71112","volume":"34","author":"A Domagala","year":"2017","unstructured":"Domagala A, Szepietowski J, Reich A. Antihistamines in the treatment of pruritus in psoriasis. Postep Dermatol Alergol. 2017;34:457\u201363.","journal-title":"Postep Dermatol Alergol"},{"key":"206_CR58","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1159\/000079211","volume":"5","author":"B Wi\u015bnicka","year":"2004","unstructured":"Wi\u015bnicka B, Szepietowski J, Reich A, Orda A. Histamine, substance P and calcitonin gene-related peptide plasma concentration and pruritus in patients suffering from psoriasis. Dermatol Psychosom\/Dermatologie und Psychosomatik. 2004;5:73\u20138.","journal-title":"Dermatol Psychosom\/Dermatologie und Psychosomatik"},{"key":"206_CR59","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1111\/j.1365-2133.2006.07518.x","volume":"155","author":"R Saraceno","year":"2006","unstructured":"Saraceno R, Kleyn CE, Terenghi G, Griffiths CE. The role of neuropeptides in psoriasis. Br J Dermatol. 2006;155:876\u201382.","journal-title":"Br J Dermatol"},{"key":"206_CR60","doi-asserted-by":"publisher","first-page":"64727","DOI":"10.1155\/2007\/64727","volume":"2007","author":"A Reich","year":"2007","unstructured":"Reich A, Szepietowski JC. Mediators of pruritus in psoriasis. Mediat Inflamm. 2007;2007:64727.","journal-title":"Mediat Inflamm"},{"key":"206_CR61","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1038\/s41591-020-1093-z","volume":"26","author":"TK Choueiri","year":"2020","unstructured":"Choueiri TK, Kaelin WG. Targeting the HIF2\u2013VEGF axis in renal cell carcinoma. Nat Med. 2020;26:1519\u201330.","journal-title":"Nat Med"},{"key":"206_CR62","doi-asserted-by":"publisher","first-page":"175","DOI":"10.2340\/00015555-1445","volume":"93","author":"K Krause","year":"2013","unstructured":"Krause K, Krull C, Kessler B, Lange-Asschenfeldt B, Maurer M, Metz M. Effective control of recalcitrant pruritus by bevacizumab: a possible role for vascular endothelial growth factor in chronic itch? Acta Derm Venereol. 2013;93:175\u20139.","journal-title":"Acta Derm Venereol"},{"key":"206_CR63","doi-asserted-by":"crossref","unstructured":"Gerkowicz A. Aumsauapautzaudk. The role of VEGF in psoriasis: an update. 2018;24:134\u201340.","DOI":"10.5603\/AA.2018.0019"},{"key":"206_CR64","first-page":"247","volume":"88","author":"ME Marina","year":"2015","unstructured":"Marina ME, Roman II, Constantin AM, Mihu CM, T\u0103taru AD. VEGF involvement in psoriasis. Clujul Med. 2015;88:247\u201352.","journal-title":"Clujul Med"},{"key":"206_CR65","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1038\/nrrheum.2010.8","volume":"6","author":"J Buckland","year":"2010","unstructured":"Buckland J. Anti-VEGF antibody therapy for psoriasis? Nat Rev Rheumatol. 2010;6:119.","journal-title":"Nat Rev Rheumatol"},{"key":"206_CR66","first-page":"233","volume":"6","author":"AK Weidemann","year":"2013","unstructured":"Weidemann AK, Crawshaw AA, Byrne E, Young HS. Vascular endothelial growth factor inhibitors: investigational therapies for the treatment of psoriasis. Clin Cosmet Investig Dermatol. 2013;6:233\u201344.","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"206_CR67","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1111\/j.1365-2133.2007.07935.x","volume":"156","author":"SE Chang","year":"2007","unstructured":"Chang SE, Han SS, Jung HJ, Choi JH. Neuropeptides and their receptors in psoriatic skin in relation to pruritus. Br J Dermatol. 2007;156:1272\u20137.","journal-title":"Br J Dermatol"},{"key":"206_CR68","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1046\/j.1365-2133.2003.05586.x","volume":"149","author":"M Nakamura","year":"2003","unstructured":"Nakamura M, Toyoda M, Morohashi M. Pruritogenic mediators in psoriasis vulgaris: comparative evaluation of itch-associated cutaneous factors. Br J Dermatol. 2003;149:718\u201330.","journal-title":"Br J Dermatol"},{"key":"206_CR69","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s00403-007-0745-x","volume":"299","author":"C Remr\u00f6d","year":"2007","unstructured":"Remr\u00f6d C, Lonne-Rahm S, Nordlind K. Study of substance P and its receptor neurokinin-1 in psoriasis and their relation to chronic stress and pruritus. Arch Dermatol Res. 2007;299:85\u201391.","journal-title":"Arch Dermatol Res"},{"key":"206_CR70","first-page":"769","volume":"43","author":"JC Choi","year":"2005","unstructured":"Choi JC, Yang JH, Chang SE, Choi J. Pruritus and nerve growth factor in psoriasis. Korean J Dermatol. 2005;43:769\u201373.","journal-title":"Korean J Dermatol"},{"key":"206_CR71","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1111\/j.1365-2133.2011.10347.x","volume":"165","author":"K Taneda","year":"2011","unstructured":"Taneda K, Tominaga M, Negi O, Tengara S, Kamo A, Ogawa H, et al. Evaluation of epidermal nerve density and opioid receptor levels in psoriatic itch. Br J Dermatol. 2011;165:277\u201384.","journal-title":"Br J Dermatol"},{"key":"206_CR72","doi-asserted-by":"publisher","first-page":"564","DOI":"10.2340\/00015555-2595","volume":"97","author":"P Kupczyk","year":"2017","unstructured":"Kupczyk P, Reich A, Ho\u0142ysz M, Gajda M, Wysoki\u0144ska E, Kobuszewska A, et al. Opioid receptors in psoriatic skin: relationship with itch. Acta Derm Venereol. 2017;97:564\u201370.","journal-title":"Acta Derm Venereol"},{"key":"206_CR73","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1002\/art.38995","volume":"67","author":"J Belasco","year":"2015","unstructured":"Belasco J, Louie JS, Gulati N, Wei N, Nograles K, Fuentes-Duculan J, et al. Comparative genomic profiling of synovium versus skin lesions in psoriatic arthritis. Arthritis Rheumatol. 2015;67:934\u201344.","journal-title":"Arthritis Rheumatol"},{"key":"206_CR74","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/jid.2012.194","volume":"133","author":"DA Martin","year":"2013","unstructured":"Martin DA, Towne JE, Kricorian G, Klekotka P, Gudjonsson JE, Krueger JG, et al. The emerging role of IL-17 in the pathogenesis of psoriasis: preclinical and clinical findings. J Investig Dermatol. 2013;133:17\u201326.","journal-title":"J Investig Dermatol"},{"key":"206_CR75","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbi.2014.03.004","volume":"41","author":"DM Moynes","year":"2014","unstructured":"Moynes DM, Vanner SJ, Lomax AE. Participation of interleukin 17A in neuroimmune interactions. Brain Behav Immun. 2014;41:1\u20139.","journal-title":"Brain Behav Immun"},{"key":"206_CR76","doi-asserted-by":"publisher","first-page":"98","DOI":"10.2340\/00015555-2801","volume":"98","author":"AB Kimball","year":"2018","unstructured":"Kimball AB, Luger T, Gottlieb A, Puig L, Kaufmann R, Burge R, et al. Long-term impact of ixekizumab on psoriasis itch severity: results from a phase III clinical trial and long-term extension. Acta Derm Venereol. 2018;98:98\u2013102.","journal-title":"Acta Derm Venereol"},{"key":"206_CR77","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1111\/jdv.15450","volume":"33","author":"B Elewski","year":"2019","unstructured":"Elewski B, Alexis AF, Lebwohl M, Stein Gold L, Pariser D, Del Rosso J, et al. Itch: an under-recognized problem in psoriasis. J Eur Acad Dermatol Venereol. 2019;33:1465\u201376.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"206_CR78","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.jaad.2009.08.026","volume":"62","author":"A Menter","year":"2010","unstructured":"Menter A, Korman NJ, Elmets CA, Feldman SR, Gelfand JM, Gordon KB, et al. Guidelines of care for the management of psoriasis and psoriatic arthritis: section\u00a05. Guidelines of care for the treatment of psoriasis with phototherapy and photochemotherapy. J Am Acad Dermatol. 2010;62:114\u201335.","journal-title":"J Am Acad Dermatol"},{"key":"206_CR79","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.jid.2017.05.039","volume":"138","author":"C Th\u00e9r\u00e9n\u00e9","year":"2018","unstructured":"Th\u00e9r\u00e9n\u00e9 C, Brenaut E, Barnetche T, Misery L. Efficacy of systemic treatments of psoriasis on pruritus: a systemic literature review and meta-analysis. J Investig Dermatol. 2018;138:38\u201345.","journal-title":"J Investig Dermatol"},{"key":"206_CR80","doi-asserted-by":"crossref","unstructured":"Pariser DM, Bagel J, Lebwohl M, Yosipovitch G, Chien E, Spellman MC. Serlopitant for psoriatic pruritus: a phase 2 randomized, double-blind, placebo-controlled clinical trial. J Am Acad Dermatol. 2020.","DOI":"10.1016\/j.jaad.2020.01.056"},{"key":"206_CR81","doi-asserted-by":"crossref","unstructured":"Pojawa-Go\u0142\u0105b M, Jaworecka K, Reich A. NK-1 receptor antagonists and pruritus: review of current literature. Dermatol Ther. 2019:1\u201315.","DOI":"10.1007\/s13555-019-0305-2"},{"key":"206_CR82","first-page":"D1006","volume":"48","author":"JF Armstrong","year":"2020","unstructured":"Armstrong JF, Faccenda E, Harding SD, Pawson AJ, Southan C, Sharman JL, et al. The IUPHAR\/BPS Guide to PHARMACOLOGY in 2020: extending immunopharmacology content and introducing the IUPHAR\/MMV Guide to MALARIA PHARMACOLOGY. Nucleic Acids Res. 2020;48:D1006\u201321.","journal-title":"Nucleic Acids Res"},{"key":"206_CR83","doi-asserted-by":"publisher","first-page":"172702","DOI":"10.1016\/j.ejphar.2019.172702","volume":"864","author":"S Inan","year":"2019","unstructured":"Inan S, Torres-Huerta A, Jensen LE, Dun NJ, Cowan A. Nalbuphine, a kappa opioid receptor agonist and mu opioid receptor antagonist attenuates pruritus, decreases IL-31, and increases IL-10 in mice with contact dermatitis. Eur J Pharmacol. 2019;864:172702.","journal-title":"Eur J Pharmacol"},{"key":"206_CR84","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/nrdp.2017.105","volume":"4","author":"VE Baracos","year":"2018","unstructured":"Baracos VE, Martin L, Korc M, Guttridge DC, Fearon KC. Cancer-associated cachexia. Nat Rev Dis Primers. 2018;4:1\u201318.","journal-title":"Nat Rev Dis Primers"},{"key":"206_CR85","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s00005-018-0521-y","volume":"67","author":"M Giavina-Bianchi","year":"2019","unstructured":"Giavina-Bianchi M, Giavina-Bianchi P. Systemic treatment for severe atopic dermatitis. Arch Immunol Ther Exp (Warsz). 2019;67:69\u201378.","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"key":"206_CR86","doi-asserted-by":"crossref","unstructured":"DaVeiga SP. Epidemiology of atopic dermatitis: a review. Allergy Asthma Proc. 2012;33:227\u201334.","DOI":"10.2500\/aap.2012.33.3569"},{"issue":"1251","key":"206_CR87","first-page":"1258e23","volume":"124","author":"JA Odhiambo","year":"2009","unstructured":"Odhiambo JA, Williams HC, Clayton TO, Robertson CF, Asher MI, Group IPTS. Global variations in prevalence of eczema symptoms in children from ISAAC Phase Three. J Allergy Clin Immunol. 2009;124(1251):1258e23.","journal-title":"J Allergy Clin Immunol"},{"key":"206_CR88","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1097\/DER.0b013e31824a6141","volume":"23","author":"C Adler-Cohen","year":"2012","unstructured":"Adler-Cohen C, Czarnowicki T, Dreiher J, Ruzicka T, Ingber A, Harari M. Climatotherapy at the Dead Sea: an effective treatment modality for atopic dermatitis with significant positive impact on quality of life. Dermatitis. 2012;23:75\u201380.","journal-title":"Dermatitis"},{"key":"206_CR89","doi-asserted-by":"crossref","unstructured":"Marsakova A, Kudish A, Gkalpakiotis S, Jahn I, Arenberger P, Harari M. Dead Sea climatotherapy versus topical steroid treatment for atopic dermatitis children: long-term follow-up study. J Dermatol Treat. 2019:1\u20135.","DOI":"10.1080\/09546634.2019.1605138"},{"key":"206_CR90","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1016\/j.jaci.2007.11.004","volume":"121","author":"H Williams","year":"2008","unstructured":"Williams H, Stewart A, von Mutius E, Cookson W, Anderson HR, International Study of A, et al. Is eczema really on the increase worldwide? J Allergy Clin Immunol. 2008;121:947\u2013954e15.","journal-title":"J Allergy Clin Immunol"},{"key":"206_CR91","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1111\/all.13320","volume":"73","author":"K Abuabara","year":"2018","unstructured":"Abuabara K, Yu AM, Okhovat JP, Allen IE, Langan SM. The prevalence of atopic dermatitis beyond childhood: a systematic review and meta-analysis of longitudinal studies. Allergy. 2018;73:696\u2013704.","journal-title":"Allergy"},{"issue":"Suppl 1","key":"206_CR92","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1159\/000370220","volume":"66","author":"S Nutten","year":"2015","unstructured":"Nutten S. Atopic dermatitis: global epidemiology and risk factors. Ann Nutr Metab. 2015;66(Suppl 1):8\u201316.","journal-title":"Ann Nutr Metab"},{"key":"206_CR93","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1016\/0952-7915(93)90112-6","volume":"5","author":"DY Leung","year":"1993","unstructured":"Leung DY. Role of IgE in atopic dermatitis. Curr Opin Immunol. 1993;5:956\u201362.","journal-title":"Curr Opin Immunol"},{"key":"206_CR94","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/S0140-6736(20)31286-1","volume":"396","author":"SM Langan","year":"2020","unstructured":"Langan SM, Irvine AD, Weidinger S. Atopic dermatitis. Lancet. 2020;396:345\u201360.","journal-title":"Lancet"},{"key":"206_CR95","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.jaci.2006.03.046","volume":"118","author":"P-O Fiset","year":"2006","unstructured":"Fiset P-O, Leung DY, Hamid Q. Immunopathology of atopic dermatitis. J Allergy Clin Immunol. 2006;118:287.","journal-title":"J Allergy Clin Immunol"},{"key":"206_CR96","doi-asserted-by":"publisher","first-page":"630","DOI":"10.3389\/fimmu.2018.00630","volume":"9","author":"L Hulshof","year":"2018","unstructured":"Hulshof L, Overbeek SA, Wyllie AL, Chu MLJ, Bogaert D, de Jager W, et al. Exploring immune development in infants with moderate to severe atopic dermatitis. Front Immunol. 2018;9:630.","journal-title":"Front Immunol"},{"key":"206_CR97","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.cell.2013.08.057","volume":"155","author":"SR Wilson","year":"2013","unstructured":"Wilson SR, Th\u00e9 L, Batia LM, Beattie K, Katibah GE, McClain SP, et al. The epithelial cell-derived atopic dermatitis cytokine TSLP activates neurons to induce itch. Cell. 2013;155:285\u201395.","journal-title":"Cell"},{"key":"206_CR98","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1007\/s00403-002-0378-z","volume":"295","author":"A J\u00e4rvikallio","year":"2003","unstructured":"J\u00e4rvikallio A, Harvima IT, Naukkarinen A. Mast cells, nerves and neuropeptides in atopic dermatitis and nummular eczema. Arch Dermatol Res. 2003;295:2\u20137.","journal-title":"Arch Dermatol Res"},{"key":"206_CR99","doi-asserted-by":"publisher","first-page":"135","DOI":"10.4103\/0019-5154.62735","volume":"55","author":"A Hodeib","year":"2010","unstructured":"Hodeib A, El-Samad ZA, Hanafy H, El-Latief AA, El-Bendary A, Abu-Raya A. Nerve growth factor, neuropeptides and cutaneous nerves in atopic dermatitis. Indian J Dermatol. 2010;55:135\u20139.","journal-title":"Indian J Dermatol"},{"key":"206_CR100","doi-asserted-by":"publisher","first-page":"6020","DOI":"10.4049\/jimmunol.181.9.6020","volume":"181","author":"W Ding","year":"2008","unstructured":"Ding W, Stohl LL, Wagner JA, Granstein RD. Calcitonin gene-related peptide biases Langerhans cells toward Th2-type immunity. J Immunol. 2008;181:6020.","journal-title":"J Immunol"},{"key":"206_CR101","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1159\/000496538","volume":"235","author":"D Mehta","year":"2019","unstructured":"Mehta D, Granstein RD. Immunoregulatory effects of neuropeptides on endothelial cells: relevance to dermatological disorders. Dermatology. 2019;235:175\u201386.","journal-title":"Dermatology"},{"key":"206_CR102","doi-asserted-by":"publisher","first-page":"14055","DOI":"10.1523\/JNEUROSCI.1722-14.2014","volume":"34","author":"K Rogoz","year":"2014","unstructured":"Rogoz K, Andersen HH, Lagerstr\u00f6m MC, Kullander K. Multimodal use of calcitonin gene-related peptide and substance P in itch and acute pain uncovered by the elimination of vesicular glutamate transporter 2 from transient receptor potential cation channel subfamily V member 1 neurons. J Neurosci. 2014;34:14055.","journal-title":"J Neurosci"},{"key":"206_CR103","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1111\/j.1365-2230.1995.tb01378.x","volume":"20","author":"L Ostlere","year":"1995","unstructured":"Ostlere L, Cowen T, Rustin M. Neuropeptides in the skin of patients with atopic dermatitis. Clin Exp Dermatol. 1995;20:462\u20137.","journal-title":"Clin Exp Dermatol"},{"key":"206_CR104","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/S0190-9622(94)70213-6","volume":"31","author":"M-A Morren","year":"1994","unstructured":"Morren M-A, Przybilla B, Bamelis M, Heykants B, Reynaers A, Degreef H. Atopic dermatitis: triggering factors. J Am Acad Dermatol. 1994;31:467\u201373.","journal-title":"J Am Acad Dermatol"},{"key":"206_CR105","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1517\/14656566.2010.484420","volume":"11","author":"T Patel","year":"2010","unstructured":"Patel T, Yosipovitch G. Therapy of pruritus. Expert Opin Pharmacother. 2010;11:1673\u201382.","journal-title":"Expert Opin Pharmacother"},{"key":"206_CR106","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/s40257-017-0335-4","volume":"19","author":"J Pavlis","year":"2018","unstructured":"Pavlis J, Yosipovitch G. Management of itch in atopic dermatitis. Am J Clin Dermatol. 2018;19:319\u201332.","journal-title":"Am J Clin Dermatol"},{"key":"206_CR107","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1111\/bjd.18025","volume":"181","author":"S St\u00e4nder","year":"2019","unstructured":"St\u00e4nder S, Yosipovitch G. Substance P and neurokinin 1 receptor are new targets for the treatment of chronic pruritus. Br J Dermatol. 2019;181:932\u20138.","journal-title":"Br J Dermatol"},{"key":"206_CR108","doi-asserted-by":"publisher","first-page":"6176","DOI":"10.1523\/JNEUROSCI.23-15-06176.2003","volume":"23","author":"M Steinhoff","year":"2003","unstructured":"Steinhoff M, Neisius U, Ikoma A, Fartasch M, Heyer G, Skov PS, et al. Proteinase-activated receptor-2 mediates itch: a novel pathway for pruritus in human skin. J Neurosci. 2003;23:6176\u201380.","journal-title":"J Neurosci"},{"key":"206_CR109","doi-asserted-by":"crossref","unstructured":"Li J, Han X, Knauss EA, Woulfe DS, Nieman MT. GPCRs in thromboinflammation and hemostasis. In: GPCRs. Elsevier, Amsterdam; 2020. p. 393\u2013414.","DOI":"10.1016\/B978-0-12-816228-6.00019-2"},{"key":"206_CR110","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1007\/s00011-003-1162-z","volume":"52","author":"M Dvorak","year":"2003","unstructured":"Dvorak M, Watkinson A, McGlone F, Rukwied R. Histamine induced responses are attenuated by a cannabinoid receptor agonist in human skin. Inflamm Res. 2003;52:238\u201345.","journal-title":"Inflamm Res"},{"key":"206_CR111","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1468-3083.2007.02351.x","volume":"22","author":"B Eberlein","year":"2008","unstructured":"Eberlein B, Eicke C, Reinhardt H-W, Ring J. Adjuvant treatment of atopic eczema: assessment of an emollient containing N-palmitoylethanolamine (ATOPA study). J Eur Acad Dermatol Venereol. 2008;22:73\u201382.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"206_CR112","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.coph.2018.11.007","volume":"46","author":"MP Pereira","year":"2019","unstructured":"Pereira MP, Mittal A, St\u00e4nder S. Current treatment strategies in refractory chronic pruritus. Curr Opin Pharmacol. 2019;46:1\u20136.","journal-title":"Curr Opin Pharmacol"},{"key":"206_CR113","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1002\/cia2.12049","volume":"2","author":"S Yu","year":"2019","unstructured":"Yu S, Li Y, Zhou Y, Follansbee T, Hwang ST. Immune mediators and therapies for pruritus in atopic dermatitis and psoriasis. J Cutan Immunol Allergy. 2019;2:4\u201314.","journal-title":"J Cutan Immunol Allergy"},{"key":"206_CR114","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1007\/s40257-018-0370-9","volume":"19","author":"JE Frampton","year":"2018","unstructured":"Frampton JE, Blair HA. Dupilumab: a review in moderate-to-severe atopic dermatitis. Am J Clin Dermatol. 2018;19:617\u201324.","journal-title":"Am J Clin Dermatol"},{"key":"206_CR115","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1002\/cpt.1058","volume":"104","author":"JD Davis","year":"2018","unstructured":"Davis JD, Bansal A, Hassman D, Akinlade B, Li M, Li Z, et al. Evaluation of potential disease-mediated drug\u2013drug interaction in patients with moderate-to-severe atopic dermatitis receiving dupilumab. Clin Pharmacol Ther. 2018;104:1146\u201354.","journal-title":"Clin Pharmacol Ther"},{"issue":"1121\u201330","key":"206_CR116","first-page":"e7","volume":"142","author":"K Kabashima","year":"2018","unstructured":"Kabashima K, Furue M, Hanifin JM, Pulka G, Wollenberg A, Galus R, et al. Nemolizumab in patients with moderate-to-severe atopic dermatitis: randomized, phase II, long-term extension study. J Allergy Clin Immunol. 2018;142(1121\u201330):e7.","journal-title":"J Allergy Clin Immunol"},{"key":"206_CR117","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1056\/NEJMoa1917006","volume":"383","author":"K Kabashima","year":"2020","unstructured":"Kabashima K, Matsumura T, Komazaki H, Kawashima M. Trial of nemolizumab and topical agents for atopic dermatitis with pruritus. N Engl J Med. 2020;383:141\u201350.","journal-title":"N Engl J Med"},{"key":"206_CR118","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.iac.2020.06.004","volume":"40","author":"M Boguniewicz","year":"2020","unstructured":"Boguniewicz M. Biologics for atopic dermatitis. Immunol Allergy Clin N Am. 2020;40:593\u2013607.","journal-title":"Immunol Allergy Clin N Am"},{"key":"206_CR119","doi-asserted-by":"publisher","first-page":"eaax2945","DOI":"10.1126\/scitranslmed.aax2945","volume":"11","author":"Y-L Chen","year":"2019","unstructured":"Chen Y-L, Gutowska-Owsiak D, Hardman CS, Westmoreland M, MacKenzie T, Cifuentes L, et al. Proof-of-concept clinical trial of etokimab shows a key role for IL-33 in atopic dermatitis pathogenesis. Sci Transl Med. 2019;11:eaax2945.","journal-title":"Sci Transl Med"},{"key":"206_CR120","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1038\/jid.2012.66","volume":"132","author":"F Cevikbas","year":"2012","unstructured":"Cevikbas F, Steinhoff M. IL-33: a novel danger signal system in atopic dermatitis. J Investig Dermatol. 2012;132:1326\u20139.","journal-title":"J Investig Dermatol"},{"key":"206_CR121","doi-asserted-by":"publisher","first-page":"6451","DOI":"10.1038\/s41598-020-63410-z","volume":"10","author":"W Pietka","year":"2020","unstructured":"Pietka W, Sundnes O, Hammarstr\u00f6m C, Zucknick M, Khnykin D, Haraldsen G. Lack of interleukin-33 and its receptor does not prevent calcipotriol-induced atopic dermatitis-like inflammation in mice. Sci Rep. 2020;10:6451.","journal-title":"Sci Rep"},{"key":"206_CR122","doi-asserted-by":"crossref","unstructured":"Du L, Hu X, Yang W, Yasheng H, Liu S, Zhang W, et al. Spinal IL\u201033\/ST2 signaling mediates chronic itch in mice through the astrocytic JAK2\u2010STAT3 cascade. Glia. Glia. 2019;67:1680\u20131693.","DOI":"10.1002\/glia.23639"},{"key":"206_CR123","doi-asserted-by":"publisher","first-page":"90","DOI":"10.5826\/dpc.0902a03","volume":"9","author":"G Rinaldi","year":"2019","unstructured":"Rinaldi G. The itch-scratch cycle: a review of the mechanisms. Dermatol Pract Concept. 2019;9:90\u20137.","journal-title":"Dermatol Pract Concept"},{"key":"206_CR124","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1038\/35106587","volume":"414","author":"V Nizet","year":"2001","unstructured":"Nizet V, Ohtake T, Lauth X, Trowbridge J, Rudisill J, Dorschner RA, et al. Innate antimicrobial peptide protects the skin from invasive bacterial infection. Nature. 2001;414:454\u20137.","journal-title":"Nature"},{"key":"206_CR125","doi-asserted-by":"crossref","unstructured":"Kim HS, Yosipovitch G. The skin microbiota and itch: is there a link? J Clin Med. 2020;9.","DOI":"10.3390\/jcm9041190"},{"key":"206_CR126","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1159\/000066140","volume":"1","author":"JW Fluhr","year":"2002","unstructured":"Fluhr JW, Elias PM. Stratum corneum pH: formation and function of the \u2018acid mantle\u2019. Exog Dermatol. 2002;1:163\u201375.","journal-title":"Exog Dermatol"},{"key":"206_CR127","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.smim.2013.09.005","volume":"25","author":"JA Sanford","year":"2013","unstructured":"Sanford JA, Gallo RL. Functions of the skin microbiota in health and disease. Semin Immunol. 2013;25:370\u20137.","journal-title":"Semin Immunol"},{"key":"206_CR128","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1111\/php.13119","volume":"95","author":"M Brandwein","year":"2019","unstructured":"Brandwein M, Fuks G, Israel A, Sabbah F, Hodak E, Szitenberg A, et al. Skin microbiome compositional changes in atopic dermatitis accompany Dead Sea climatotherapy. Photochem Photobiol. 2019;95:1446\u201353.","journal-title":"Photochem Photobiol"},{"key":"206_CR129","doi-asserted-by":"publisher","first-page":"970","DOI":"10.3390\/jcm4050970","volume":"4","author":"DJ Panther","year":"2015","unstructured":"Panther DJ, Jacob SE. The importance of acidification in atopic eczema: an underexplored avenue for treatment. J Clin Med. 2015;4:970\u20138.","journal-title":"J Clin Med"},{"key":"206_CR130","first-page":"28","volume":"12","author":"CE Psomadakis","year":"2019","unstructured":"Psomadakis CE, Han G. New and emerging topical therapies for psoriasis and atopic dermatitis. J Clin Aesthet Dermatol. 2019;12:28\u201334.","journal-title":"J Clin Aesthet Dermatol"},{"key":"206_CR131","doi-asserted-by":"crossref","unstructured":"Bigliardi PL. Role of Skin pH in Psoriasis. Curr Probl Dermatol. 2018;54:108\u201314.","DOI":"10.1159\/000489524"},{"key":"206_CR132","doi-asserted-by":"publisher","first-page":"2026","DOI":"10.1038\/jid.2011.168","volume":"131","author":"KA Capone","year":"2011","unstructured":"Capone KA, Dowd SE, Stamatas GN, Nikolovski J. Diversity of the human skin microbiome early in life. J Investig Dermatol. 2011;131:2026\u201332.","journal-title":"J Investig Dermatol"},{"key":"206_CR133","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1001\/jamadermatol.2019.2855","volume":"155","author":"MJ Gooderham","year":"2019","unstructured":"Gooderham MJ, Forman SB, Bissonnette R, Beebe JS, Zhang W, Banfield C, et al. Efficacy and safety of oral Janus kinase 1 inhibitor abrocitinib for patients with atopic dermatitis: a phase 2 randomized clinical trial. JAMA Dermatol. 2019;155:1371\u20139.","journal-title":"JAMA Dermatol"},{"key":"206_CR134","doi-asserted-by":"publisher","first-page":"249","DOI":"10.2147\/CCID.S55942","volume":"8","author":"S Inui","year":"2015","unstructured":"Inui S. Nalfurafine hydrochloride to treat pruritus: a review. Clin Cosmet Investig Dermatol. 2015;8:249.","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"206_CR135","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1007\/s00105-006-1180-1","volume":"57","author":"S St\u00e4nder","year":"2006","unstructured":"St\u00e4nder S, Reinhardt H, Luger T. Topische cannabinoidagonisten. Der Hautarzt. 2006;57:801\u20137.","journal-title":"Der Hautarzt"},{"key":"206_CR136","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1016\/j.jaad.2020.01.036","volume":"82","author":"C Avila","year":"2020","unstructured":"Avila C, Massick S, Kaffenberger BH, Kwatra SG, Bechtel M. Cannabinoids for the treatment of chronic pruritus: a review. J Am Acad Dermatol. 2020;82:1205\u201312.","journal-title":"J Am Acad Dermatol"},{"key":"206_CR137","doi-asserted-by":"publisher","first-page":"e9","DOI":"10.1016\/j.jdermsci.2017.02.025","volume":"86","author":"N Takahashi","year":"2017","unstructured":"Takahashi N, Tominaga M, Kamata Y, Umehara Y, Matsuda H, Suga Y, et al. Involvement of opioid systems in itch-related behavior of imiquimod-induced psoriasis-like dermatitis model. J Dermatol Sci. 2017;86:e9.","journal-title":"J Dermatol Sci"},{"key":"206_CR138","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1111\/j.1365-2044.2007.05098.x","volume":"62","author":"PF Lockington","year":"2007","unstructured":"Lockington PF, Fa\u2019aea P. Subcutaneous naloxone for the prevention of intrathecal morphine induced pruritus in elective Caesarean delivery. Anaesthesia. 2007;62:672\u20136.","journal-title":"Anaesthesia"},{"key":"206_CR139","doi-asserted-by":"publisher","first-page":"159","DOI":"10.5021\/ad.2016.28.2.159","volume":"28","author":"J Lee","year":"2016","unstructured":"Lee J, Shin JU, Noh S, Park CO, Lee KH. Clinical efficacy and safety of naltrexone combination therapy in older patients with severe pruritus. Ann Dermatol. 2016;28:159\u201363.","journal-title":"Ann Dermatol"},{"key":"206_CR140","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1111\/jdv.13679","volume":"30","author":"U Nygaard","year":"2016","unstructured":"Nygaard U, Hvid M, Johansen C, Buchner M, F\u00f6lster-Holst R, Deleuran M, et al. TSLP, IL-31, IL-33 and sST 2 are new biomarkers in endophenotypic profiling of adult and childhood atopic dermatitis. J Eur Acad Dermatol Venereol. 2016;30:1930\u20138.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"206_CR141","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1111\/1523-1747.ep12616114","volume":"99","author":"H Renz","year":"1992","unstructured":"Renz H, Jujo K, Bradley KL, Domenico J, Gelfand EW, Leung DY. Enhanced IL-4 production and IL-4 receptor expression in atopic dermatitis and their modulation by interferon-gamma. J Investig Dermatol. 1992;99:403\u20138.","journal-title":"J Investig Dermatol"},{"key":"206_CR142","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1111\/all.14151","volume":"75","author":"A Le Floc\u2019h","year":"2020","unstructured":"Le Floc\u2019h A, Allinne J, Nagashima K, Scott G, Birchard D, Asrat S, et al. Dual blockade of IL\u20104 and IL\u201013 with dupilumab, an IL\u20104R\u03b1 antibody, is required to broadly inhibit type 2 inflammation. Allergy. 2020;75:1188.","journal-title":"Allergy"},{"key":"206_CR143","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.2147\/DDDT.S243053","volume":"14","author":"HH Kariyawasam","year":"2020","unstructured":"Kariyawasam HH, James LK, Gane SB. Dupilumab: clinical efficacy of blocking IL-4\/IL-13 signalling in chronic rhinosinusitis with nasal polyps. Drug Des Dev Ther. 2020;14:1757.","journal-title":"Drug Des Dev Ther"},{"key":"206_CR144","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1111\/all.13954","volume":"75","author":"T Bieber","year":"2020","unstructured":"Bieber T. Interleukin-13: targeting an underestimated cytokine in atopic dermatitis. Allergy. 2020;75:54\u201362.","journal-title":"Allergy"}],"container-title":["Pharmacological Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43440-020-00206-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s43440-020-00206-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43440-020-00206-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T22:50:12Z","timestamp":1697583012000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s43440-020-00206-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,18]]},"references-count":144,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["206"],"URL":"https:\/\/doi.org\/10.1007\/s43440-020-00206-y","relation":{},"ISSN":["1734-1140","2299-5684"],"issn-type":[{"value":"1734-1140","type":"print"},{"value":"2299-5684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,18]]},"assertion":[{"value":"13 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}